Compare CPNG & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPNG | IQV |
|---|---|---|
| Founded | 2010 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Durable Goods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.6B | 41.3B |
| IPO Year | 2021 | 2013 |
| Metric | CPNG | IQV |
|---|---|---|
| Price | $21.08 | $238.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 15 |
| Target Price | $37.00 | ★ $240.60 |
| AVG Volume (30 Days) | ★ 19.4M | 1.2M |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.21 | ★ 7.30 |
| Revenue | ★ $33,664,000,000.00 | $15,904,000,000.00 |
| Revenue This Year | $17.68 | $6.15 |
| Revenue Next Year | $17.21 | $5.36 |
| P/E Ratio | $101.68 | ★ $32.54 |
| Revenue Growth | ★ 16.63 | 3.85 |
| 52 Week Low | $19.02 | $134.65 |
| 52 Week High | $34.08 | $247.05 |
| Indicator | CPNG | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 31.60 | 61.95 |
| Support Level | $20.72 | $238.49 |
| Resistance Level | $23.66 | $244.82 |
| Average True Range (ATR) | 0.68 | 5.14 |
| MACD | -0.06 | 0.40 |
| Stochastic Oscillator | 10.32 | 68.12 |
Coupang is South Korea's largest e-commerce platform that sells both owned and third-party inventory. Headquartered in the US, Coupang operates e-commerce businesses mainly in South Korea and Taiwan. The company has built an integrated logistics network that covers the entirety of South Korea, with extensive fulfillment centers that ensure timely delivery, even for orders placed seconds before midnight. Outside of its bread-and-butter e-commerce business, Coupang has expanded into Rocket delivery services to third-party merchants (fulfillment and logistics by Coupang), online grocery delivery Rocket Fresh, online meal delivery (Eats), e-commerce in Taiwan, luxury e-commerce (Farfetch), and travel.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.